Autres langues Zai Lab Limited

Actions

ZLAB

US98887Q1040

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
15,91 ^USD	+1,08%		+13,08%	-41,79%

17/04	Les actions asiatiques négociées aux États-Unis sous forme de certificats de dépôt américains restent stables mercredi matin	MT
11/04	Le PDG de Zai Lab et d'autres personnes "ne prévoient pas" de vendre des actions de la société jusqu'à la fin de l'année 2024	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading	17/04
Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024	15/04
Zai Lab Statement on Executive Management Team's Agreement on Share Activities	12/04
Zai Lab CEO, Others 'Do Not Anticipate' Selling Company Shares in Remainder of 2024	11/04
Zai Lab Statement on Executive Management Team’s Agreement on Share Activities	11/04
Zai Lab Changes Record Date	11/04
Zai Lab Grants Share Options, Restricted Share Units to Eligible Personnel	05/04
Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI Meets Primary Endpoint	02/04
Zai Lab Presentations at AACR 2024 Annual Meeting to Showcase Ongoing Clinical Studies in Key Global Oncology Programs	02/04
Bristol-Myers Squibb Therapy for Pretreated Non-Small Cell Lung Cancer Meets Primary Endpoint	01/04
Zai Lab Partner Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or Metastatic...	01/04
Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases	28/03
Zai Lab Reports Lesser Loss in 2023	28/03
Zai Lab, Novocure Say TTFields Therapy Delays Intracranial Progression in Non-Small Cell Lung Cancer Brain Metastases Patients	27/03
Zai Lab Partner Novocure Announces METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer	27/03
Zai Lab Partner Novocure Announces Metis Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating A Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung Cancer	27/03
Asian Equities Traded in the US as American Depositary Receipts Higher in Wednesday Trading	20/03
Asian Equities Traded in the US as American Depositary Receipts End Week Lower in Friday Trading	15/03
Zai Lab to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate (ADC) for Treatment of Solid Tumors	14/03
Zai Lab Limited to Present Data Highlighting ZL-1310, a Novel Antibody-Drug Conjugate for Treatment of Solid Tumors	14/03

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Zai Lab Limited

Actions

ZLAB

US98887Q1040

Autres langues

Filtres